Filter By Category
Archives
Share on -
EDOTREOTIDE
Generic Name: EDOTREOTIDE
ABSTRACT -
Edotreotide is a somatostatin analog peptide used as a chelator-conjugated ligand for radiolabeled imaging or peptide-receptor radionuclide therapy contexts. The final safety profile depends on radionuclide and formulation.
DOSAGE -
Dose is radionuclide-, indication-, and protocol-specific and is expressed in activity units for radiopharmaceutical use.
SIDE EEFECTS -
- Nausea or vomiting
- Flushing
- Headache
- Injection-site reaction
- Renal or marrow effects when radiolabeled therapeutically
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Hypersensitivity to peptide, chelator, excipients, or radiopharmaceutical components
- Rash, dyspnea, hypotension, or anaphylaxis
DRUG INTERACTIONS-
- Somatostatin analogs may compete with receptor binding
- Nephrotoxic therapies may increase renal risk for radiotherapeutic products
- Radiation-sensitizing therapies require protocol review
PREAUTONS–
- Use radiation-safety procedures when radiolabeled
- Monitor renal function, blood counts, and hormonal symptoms
- Pregnancy and lactation require strict radiopharmaceutical precautions
WARNINGS –
- Radiation exposure, renal toxicity, and myelosuppression may occur with therapeutic radiolabeled products
Share on -
. Developed by